IgG4-related lung disease with multifocal pulmonary consolidations near the pleura: A case report

Rationale: Immunoglobulin G4 (IgG4)-related disease (IgG4-RD) is a systemic immune-mediated condition that can cause fibroinflammatory lesions in multiple organs. Approximately 35% of IgG4-RD patients have some symptoms in the chest and IgG4-related lung disease (IgG4-RLD) is observed in about 10% of IgG4-RD cases. In addition, it is thought that glucocorticoid therapy is effective for IgG4-RD and IgG4-RLD. It is difficult to diagnose IgG4-RLD complicated with another lung disease. Patient concerns: An 85-year-old Japanese man was hospitalized due to pulmonary consolidations just below the pleura in chest computed tomography while being treated with antibiotics. Previously, an upper lobectomy of the right lung was performed for an upper lung mucinous adenocarcinoma, and he was diagnosed with chronic obstructive pulmonary disease. Although he took antibiotics before admission, C-reactive protein levels were elevated. Diagnosis: IgG4 levels were also elevated (IgG4; 733 mg/dL), and lung biopsy histology showed an abundance of IgG4-positive plasma cell infiltration; about 40% of the affected area was occupied by such infiltration. Based on such findings, we finally diagnosed him as IgG4-RLD. Interventions: We administered 20 mg/d prednisolone. Outcomes: About 2 weeks after administration of prednisolone by intravenous injection, his multifocal pulmonary consolidations just below the pleura were markedly improved and his pulmonary symptoms disappeared. Four weeks after glucocorticoid therapy, IgG4 levels decreased from 831 mg/dL (peak) to 547 mg/dL. Lessons: We should consider IgG4-RLD, a rare disease, when lesions are detected as pulmonary consolidations near the pleura and are unresponsive to antibiotic therapy. Glucocorticoid therapy, however, is very effective for such IgG4-RLD.

[1]  Amita Sharma,et al.  The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease , 2019, Annals of the rheumatic diseases.

[2]  D. Nandurkar,et al.  IgG4 Related Lung Disease , 2016, Canadian respiratory journal.

[3]  R. Feng,et al.  Intrathoracic Involvements of Immunoglobulin G4-Related Sclerosing Disease , 2015, Medicine.

[4]  J. Stone,et al.  IgG4-related disease , 2015, The Lancet.

[5]  K. Honma,et al.  Lung cancer complicated with IgG4-related disease of the lung. , 2014, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[6]  Y. Kawabata,et al.  Immunoglobulin G4‐related lung disease: Clinicoradiological and pathological features , 2013, Respirology.

[7]  H. Sekiguchi,et al.  Pulmonary manifestations of immunoglobulin G4-related sclerosing disease , 2011, European Respiratory Journal.

[8]  O. Matsui,et al.  IgG4-related Lung and Pleural Disease: A Clinicopathologic Study of 21 Cases , 2009, The American journal of surgical pathology.

[9]  G. Rossi,et al.  Recurrent pleural and pericardium effusions in a white woman with IgG4-related syndrome. , 2009, The American journal of surgical pathology.

[10]  O. Matsui,et al.  Immunoglobulin G4-related lung disease: CT findings with pathologic correlations. , 2009, Radiology.

[11]  K. Tsubota,et al.  Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders , 2008, Annals of the rheumatic diseases.

[12]  M. Moriyama,et al.  Peripheral CD4+ T cells showing a Th2 phenotype in a patient with Mikulicz's disease associated with lymphadenopathy and pleural effusion , 2008, Modern rheumatology.

[13]  Y. Nakanuma,et al.  IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. , 2005, Human pathology.